AstraZeneca PLC (AZN)
64.25
+1.05
(+1.66%)
USD |
NASDAQ |
Nov 21, 16:00
64.28
+0.03
(+0.05%)
After-Hours: 18:08
AstraZeneca Net Income (Quarterly): 1.429B for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.429B |
| June 30, 2024 | 1.927B |
| March 31, 2024 | 2.179B |
| December 31, 2023 | 960.00M |
| September 30, 2023 | 1.374B |
| June 30, 2023 | 1.818B |
| March 31, 2023 | 1.803B |
| December 31, 2022 | 901.00M |
| September 30, 2022 | 1.64B |
| June 30, 2022 | 360.00M |
| March 31, 2022 | 386.00M |
| December 31, 2021 | -347.00M |
| September 30, 2021 | -1.652B |
| June 30, 2021 | 550.00M |
| March 31, 2021 | 1.561B |
| December 31, 2020 | 1.012B |
| September 30, 2020 | 648.00M |
| June 30, 2020 | 756.00M |
| March 31, 2020 | 780.00M |
| December 31, 2019 | 313.00M |
| September 30, 2019 | 299.00M |
| June 30, 2019 | 130.00M |
| March 31, 2019 | 593.00M |
| December 31, 2018 | 1.034B |
| September 30, 2018 | 431.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 350.00M |
| March 31, 2018 | 340.00M |
| December 31, 2017 | 1.301B |
| September 30, 2017 | 686.00M |
| June 30, 2017 | 477.00M |
| March 31, 2017 | 537.00M |
| December 31, 2016 | 1.842B |
| September 30, 2016 | 1.014B |
| June 30, 2016 | -3.00M |
| March 31, 2016 | 646.00M |
| December 31, 2015 | 808.00M |
| September 30, 2015 | 770.00M |
| June 30, 2015 | 697.00M |
| March 31, 2015 | 550.00M |
| December 31, 2014 | -321.00M |
| September 30, 2014 | 254.00M |
| June 30, 2014 | 796.00M |
| March 31, 2014 | 504.00M |
| December 31, 2013 | -524.00M |
| September 30, 2013 | 1.246B |
| June 30, 2013 | 823.00M |
| March 31, 2013 | 1.011B |
| December 31, 2012 | 1.507B |
| September 30, 2012 | 1.511B |
| June 30, 2012 | 1.597B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-1.652B
Minimum
Sep 2021
2.179B
Maximum
Mar 2024
919.90M
Average
930.50M
Median
Net Income (Quarterly) Benchmarks
| GSK PLC | -75.47M |
| Amgen Inc | 2.83B |
| Johnson & Johnson | 2.694B |
| Sanofi SA | 3.096B |
| Moderna Inc | 13.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 13.56B |
| Total Expenses (Quarterly) | 11.46B |
| EPS Diluted (Quarterly) | 0.455 |
| Enterprise Value | 221.25B |
| Gross Profit Margin (Quarterly) | 77.29% |
| Profit Margin (Quarterly) | 10.53% |
| Earnings Yield | 3.25% |
| Operating Earnings Yield | 5.36% |
| Normalized Earnings Yield | 3.855 |